Targeted muscle reinnervation (TMR) is a surgical procedure that reroutes severed nerves from an amputated limb into nearby muscles that still remain in the residual limb. Once those nerves grow into their new muscle targets, the muscles respond to brain signals originally meant for the missing hand, arm, or leg. This serves two purposes: it gives the nerves a healthy destination (preventing painful nerve tangles called neuromas), and it creates electrical signals on the skin’s surface that can be picked up by a prosthetic limb for more intuitive control.
How the Surgery Works
When a limb is amputated, the nerves that once controlled it are cut. Left on their own, those severed nerve endings try to regrow but have nowhere to go. They often form disorganized clumps of nerve tissue called neuromas, which can cause significant pain. TMR gives those nerves a productive destination.
During the procedure, a surgeon identifies the major nerves that previously controlled the missing limb and redirects them to small, nearby “target” muscles. These are muscles that no longer serve a mechanical purpose after the amputation. The surgeon first cuts the target muscle’s original nerve supply so it becomes a blank slate. Then the amputated limb’s nerve is connected directly to the point where the nerve enters that muscle, keeping the regeneration distance as short as possible.
What happens next is biological. The cut nerve’s proximal end (the part still connected to the brain and spinal cord) sends out new growth processes that follow the path of the old nerve into the muscle, eventually forming new connections at muscle fiber junctions. The transferred nerves are typically much larger than the recipient nerves they’re joined to. A major arm nerve might be 8 to 10 millimeters across, while the small motor nerve entering the target muscle is roughly 1 millimeter. This size mismatch actually works in the patient’s favor: the flood of nerve fibers maximizes the chance that every muscle fiber gets reinnervated, a phenomenon called hyper-reinnervation. Research in animal models shows this leads to stronger muscle recovery, and it works even when the amputation happened years earlier.
Controlling a Prosthetic Limb
TMR was originally developed in 2002 by a plastic surgeon and a rehabilitation physician at Northwestern University as a way to improve prosthetic arm control. The core idea is straightforward: when you think about closing your missing hand, the nerve that used to make that happen now causes a specific patch of muscle in your residual limb to contract. That contraction produces an electrical signal on the skin’s surface. Sensors in a myoelectric prosthesis detect that signal and translate it into movement of the prosthetic hand.
Before TMR, most upper limb amputees had only one or two usable muscle signals to work with, which severely limits what a prosthetic arm can do. After TMR, patients in published case series have generated three to five independent signals, each corresponding to a different intended movement. More signals mean more degrees of freedom: the ability to open and close the hand, rotate the wrist, and bend the elbow as separate, intuitive actions rather than toggling through modes with a switch.
Treating and Preventing Chronic Pain
The pain-management benefits of TMR have become just as significant as the prosthetic applications. After amputation, two types of chronic pain are common: phantom limb pain (pain that feels like it’s coming from the limb that’s no longer there) and residual limb pain (pain at the stump itself, often caused by neuromas). Both can be debilitating and difficult to treat with medication alone.
TMR addresses the root problem by giving severed nerves a functional endpoint, which prevents neuromas from forming in the first place or resolves existing ones. In a controlled trial published in the Annals of Surgery, 72% of TMR patients had no phantom limb pain or only mild phantom limb pain at their longest follow-up, compared with 40% of patients who received standard surgical treatment. Over time, the TMR group showed significantly greater reductions in phantom limb pain scores.
Lower limb amputees see similar results. In a study of 36 lower extremity TMR patients, overall pain scores dropped from an average of 7.3 out of 10 before surgery to 2.6 afterward. Residual limb pain saw the largest improvement, falling from 8.1 to 1.8. Half of lower limb TMR patients were still using some form of pain medication at follow-up, but that represents a meaningful reduction from baseline reliance on narcotics and nerve-modulating drugs.
Timing Matters: During or After Amputation
TMR can be performed at two points: during the initial amputation surgery (called acute or primary TMR) or as a separate procedure months or years later (delayed TMR). The evidence increasingly favors doing it at the time of amputation when possible.
In a comparison of the two approaches, only 1% of patients who received TMR during their amputation developed recurrent symptomatic neuromas, versus 19% of those who had delayed TMR. The acute group also reported significantly lower phantom limb pain and residual limb pain scores. Performing TMR upfront prevents the nerve problems from developing rather than trying to reverse them after they’ve taken hold.
Despite these findings, there is no uniform standard for how surgeons handle nerves during amputations. Many surgical textbooks and national guidelines still do not mention nerve handling during amputation surgery at all. The current default in many settings remains traction neurectomy, where the nerve is simply pulled and cut so it retracts into surrounding tissue. Ongoing clinical trials are comparing primary TMR directly against this standard approach to build the evidence base for changing practice.
Who Can Get TMR
TMR applies to both upper and lower limb amputees. It was developed for above-elbow and shoulder-level amputations, where prosthetic control is most challenging, but has since expanded to below-elbow amputations and transtibial (below-knee) and transfemoral (above-knee) amputations. For lower limb amputees, the primary goal is usually pain management rather than prosthetic control, since lower limb prosthetics rely more on mechanical design than muscle signals.
The procedure works even in patients whose amputations happened years ago. Because of the hyper-reinnervation effect, the large transferred nerves can successfully grow into target muscles long after the original injury. This means TMR is not limited to recent amputees, though earlier intervention produces better pain outcomes.
Recovery and Nerve Regrowth
After surgery, the transferred nerves need time to grow into their new muscle targets. Nerves regenerate slowly, typically about an inch per month, so the timeline depends on how far the nerve needs to travel. Surgeons minimize this distance by connecting the nerve directly at the muscle’s motor point. For most patients, early signs of muscle reinnervation appear within a few months, though full signal strength for prosthetic use can take longer.
During this waiting period, patients may work with therapists to practice the mental movements (thinking about opening a hand or flexing a wrist) that will eventually drive the reinnervated muscles. Once the nerve connections mature and the muscles produce consistent electrical signals, prosthetic fitting and training can begin.
When TMR Doesn’t Work
TMR is not a guaranteed success. Revision surgeries have identified several reasons the procedure can fail. Excess slack in the transferred nerve can cause it to kink, disrupting nerve growth. A significant size mismatch between donor and recipient nerves, while normally advantageous, can become a problem if the connection is poorly executed. Placing the nerve connection too close to the skin surface, choosing an inappropriate target muscle, or failing to completely cut the target muscle’s original nerve supply can all compromise the result. When the original innervation isn’t fully eliminated, the target muscle ends up responding to two different nerve signals, making it useless for clean prosthetic control.
These failures are relatively uncommon but represent real limitations. Surgeons performing TMR need specific training in nerve transfer techniques, and the procedure is more widely available at specialized centers than at general hospitals.